Roivant Sciences Ltd. (ROIV) Discusses Phase 3 Results for Brepocitinib in Non-Infectious Uveitis - Slideshow
2026-10-24. The following slide deck was published by Roivant Sciences Ltd.
Equity
Roivant Sciences Ltd. (ROIV) Stock — Today's Move
$36.05
$-0.44 today
ROIV is down 1.21% today. Volume is 9.87M vs a 30-day average of 7.51M (1.31x).
Day High
$36.91
Day Low
$35.66
Open
$36.66
Prev Close
$36.49
Volume
9.87M
Avg Vol (30d)
7.51M
52-Wk High
$42.50
52-Wk Low
$18.27
Sector
—
Today's Move
-1.21%
Next Earnings
Not in next 6 wks
52-wk low $18.2752-wk high $42.50
ROIV is 73% of the way from its 52-week low to its high.
Indicators:
Close price · volume bars (dashed line = average volume) · news that day (2M–1Y) — hover or tap the chart. Indicators are for education, not trading advice.
Why is ROIV moving today?
Roivant Sciences’ Brepocitinib Delivers Positive Phase III Uveitis Results
Roivant Sciences (NASDAQ:ROIV) reported positive Phase III results from its CLARITY-1 and CLARITY-2 studies evaluating brepocitinib, which the company referred to as Brepo, in non…
Why Is Roivant Sciences Stock Surging Wednesday?
Roivant (ROIV) shares jump as Phase 3 CLARITY trials show brepocitinib effectively treats noninfectious uveitis & reduces steroid reliance.
Roivant Sciences stock surges on positive uveitis trial data
Investing.com -- Roivant Sciences Ltd (NASDAQ:ROIV) shares jumped 9% in premarket trading Wednesday after the company announced brepocitinib met all Phase 3 endpoints in trials fo…
Immunovant to Report Financial Results for the Second Fiscal Quarter Ended September 30, 2026, and Provide Business Update on Monday, November 9, 2026
DURHAM, N.C., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT) today announced that it will report its financial results for the second fiscal quarter ended Septe…
Related Movers
XP
▼ -48.36%
XP Inc.
Gap Stock Movers: SGRY Leads Gap-Ups and XP Leads Gap-Downs in Today's Session
$15.71
-$14.71
INTR
▼ -34.91%
Inter & Co. Inc.
S&P Index Addition Could Change The Case For Inter (INTR) Stock
$4.68
-$2.51
BBD
▼ -28.01%
Banco Bradesco Sa
Most Active Stocks on Oct. 26: RCT, NU and BBD Top Volume
$2.93
-$1.14
SBS
▼ -26.09%
Companhia de saneamento Basico
$4.73
-$1.67
FAQ — ROIV
Why is ROIV moving today?
ROIV is down 1.21% in the current session. Scroll to the news section below to see the most recent headlines and catalysts driving the move.
Is Roivant Sciences Ltd. a good stock to buy today?
WeeklyTrader.io does not provide financial advice. Always verify catalysts, assess risk, and conduct your own research before making any investment decision.
What is ROIV's average volume?
Average volume for ROIV is approximately 7.51M shares per day based on the trailing 30 sessions.